Discover
XBIO
Xenetic Biosciences, Inc.
2.70
3 x 2.68
414 x 2.75
bid
ask
-
0.11
3.91%
04:00 PM
| Ytd | 24.42% | |
| 1y | -26.03% |
2.69
day range
2.99
1.90
52 week range
13.93
| Open | 2.75 | Prev Close | 2.81 | Low | 2.69 | High | 2.99 | Mkt Cap | 5.10M |
| Vol | 39.87K | Avg Vol | 16.04K | EPS | -1.20 | P/E | -2.25 | Forward P/E | -6.20 |
| Beta | 2.19 | Short Ratio | 0.77 | Inst. Own | 2.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.99 | 200-d Avg | 2.91 | 1yr Est | 4.00 |
| Income Statement | |||
| Total Revenue | 806.92K | ||
| Revenues (USD) | 806.92K | ||
| Gross Profit | 806.92K | ||
| Operating Expenses | 1.31M | ||
| Research and Development Expense | 661.44K | ||
| Selling, General and Administrative Expense | 647.60K | ||
| Operating Income | -502.12K | ||
| Net Income | -456.38K | ||
| Net Income Common Stock | -456.38K | ||
| Net Income Common Stock (USD) | -456.38K | ||
| Consolidated Income | -456.38K | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -456.38K | ||
| Earning Before Interest & Taxes (USD) | -456.38K | ||
| Weighted Average Shares | 2.29M | ||
| Weighted Average Shares Diluted | 2.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.35M | ||
| Cash and Equivalents (USD) | 7.35M | ||
| Current Assets | 7.60M | ||
| Total Assets | 7.91M | ||
| Current Liabilities | 958.24K | ||
| Total Liabilities | 958.24K | ||
| Accumulated Retained Earnings (Deficit) | -200.33M | ||
| Accumulated Other Comprehensive Income | 253.73K | ||
| Shareholders Equity | 6.95M | ||
| Shareholders Equity (USD) | 6.95M | ||
| Assets Non-Current | 313.92K | ||
| Trade and Non-Trade Payables | 558.81K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -536.38K | ||
| Net Cash Flow from Operations | -536.38K | ||
| Share Based Compensation | 11.31K | ||